Paolo Pinton Lab__Signal Transduction
Home – Lab members – Research – Lab facilities – Publications – Selected Publications — Lab funds – Map – Contacts & Information
- Govoni M, Bortoluzzi A, Padovan M, Silvagni E, Borrelli M, Donelli F, Ceruti S, Trotta F (2016) The diagnosis and clinical management of the neuropsychiatric manifestations of lupus. J Autoimmun 74:41-72
- Caprioli M, Carrara G, Sakellariou G, Silvagni E, Scirè CA (2018) Influence of aromatase inhibitors therapy on the occurrence of rheumatoid arthritis in women with breast cancer: results from a large population-based study of the Italian Society for Rheumatology. RMD Open 3(2):e000523
- Generali E, Carrara G, Selmi C, Verstappen SMM, Zambon A, Bortoluzzi A, Silvagni E, Scirè CA (2018) Comparison of the risk of hospitalisation for cardiovascular events in patients with rheumatoid arthritis treated with tocilizumab and etanercept. Clin Exp Rheumatol 36(2):310-313
- Bortoluzzi A, Furini F, Generali E, Silvagni E, Luciano N, Scirè CA (2018) One year in review 2018: novelties in the treatment of rheumatoid arthritis. Clin Exp Rheumatol 36(3):347-361
- Silvagni E, Bortoluzzi A, Carrara G, Zanetti A, Govoni M, Scirè CA (2018) Comparative effectiveness of first-line biological monotherapy use in rheumatoid arthritis: a retrospective analysis of the RECord-linkage On Rheumatic Diseases study on health care administrative databases. BMJ Open 8(9):e021447
- Bortoluzzi A, Silvagni E, Furini F, Piga M, Govoni M (2019) Peripheral nervous system involvement in systemic lupus erythematosus: a review of the evidence. Clin Exp Rheumatol 37(1):146-155
- Carrara G, Bortoluzzi A, Sakellariou G, Silvagni E, Zanetti A, Govoni M, Scirè CA (2019) Risk of hospitalisation for serious bacterial infections in patients with rheumatoid arthritis treated with biologics. Analysis from the RECord linkage On Rheumatic Disease study of the Italian Society for Rheumatology. Clin Exp Rheumatol 37(1):60-66
- Bortoluzzi A, Piga M, Silvagni E, Chessa E, Mathieu A, Govoni M (2019) Peripheral nervous system involvement in systemic lupus erythematosus: a retrospective study on prevalence, associated factors and outcome. Lupus 28(4):465-474
- Silvagni E, Di Battista M, Bonifacio AF, Zucchi D, Governato G, Scirè CA (2019) One year in review 2019: novelties in the treatment of rheumatoid arthritis. Clin Exp Rheumatol 37(4):519-534
- Silvagni E, Bortoluzzi A, Ciancio G, Govoni M (2019) Biological and synthetic target DMARDs in psoriatic arthritis. Pharmacol Res 1:104473
- Silvagni E, Bortoluzzi A, Borrelli M, Padovan M, Furini F, Govoni M (2020) Conventional brain Magnetic Resonance Imaging in the longitudinal evaluation of newly diagnosed Systemic Lupus Erythematosus patients: a retrospective analysis from a single-center cohort. Lupus 29(5):499-504
- Silvagni E, Giollo A, Sakellariou G, Ughi N, D'Amico ME, Scirè CA, Huizinga TWJ (2020) One year in review 2020: novelties in the treatment of rheumatoid arthritis. Clin Exp Rheumatol 38(2):181-194
- Bortoluzzi A, Chighizola CB, Fredi M, Raschi E, Bodio C, Privitera D, Gonelli A, Silvagni E, Govoni M, Cavazzana I, Airò P, Meroni PL, Tincani A, Franceschini F, Piantoni S, Casciano F (2020) The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus. Front Immunol 11:572876
- Benaglio F, Fornaro M, Montecucco C, Raffeiner B, Di Franco M, Iannuccelli C, Conigliaro P, Lomater C, Govoni M, Silvagni E, Zanetti A, Parisi S, Carrara G, Scirè CA, Iannone F, Caporali R (2020) Methotrexate in Italian patients wiTh Rheumatoid Arthritis (MITRA study): an observational study about the use of methotrexate in early RA patients and the adherence to the EULAR 2013 recommendations. A project of the Italian Society for Rheumatology. Clin Exp Rheumatol
- Silvagni E*, Inglese F*, Bortoluzzi A, Borrelli M, Goeman JJ, Revenaz A, Groppo E, Steup-Beekman GM, Huizinga TWJ, Ronen I, de Bresser J, Fainardi E, Govoni M, Ercan E (2020) Longitudinal changes in cerebral white matter microstructure in newly diagnosed Systemic Lupus Erythematosus patients. Rheumatology (Oxford) 30:keaa677
- D’Amico ME*, Silvagni E*, Carrara G, Zanetti A, Govoni M, Scirè CA, Bortoluzzi A (2021) The role of comorbidities on therapeutic persistence of biologic agents in rheumatoid arthritis: results from the RECord-linkage On Rheumatic Disease study on administrative healthcare databases. Scandinavian Journal of Rheumatology In press
- Silvagni E, Missiroli S, Perrone M, Patergnani S, Boncompagni C, Bortoluzzi A, Govoni M, Giorgi C, Alivernini S, Pinton P, Scirè CA (2021) From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis. Front Pharmacol 12:672515
